Showing 1 of 1 PublicationsClinical Use of β-Andrenoceptor Blockade in Systemic HypertensionNadelmann J, Frishman W. Clinical Use of β-Andrenoceptor Blockade in Systemic Hypertension. Drugs 1990, 39: 862-876. PMID: 1973382, DOI: 10.2165/00003495-199039060-00005.ChaptersCitationsMeSH Keywords and ConceptsMeSH KeywordsAdrenergic beta-AntagonistsAdultAgedHumansHypertensionMiddle AgedConceptsΒ-blockersSystemic hypertensionBlood pressureMembrane-stabilising activityIntrinsic sympathomimetic activityDuration of actionSympathomimetic activityPatient groupPharmacokinetic differencesΒ1-selectivityIndividual patientsClinical usePatientsRelative potencyHypertensionBlockadeDownload Full List
Clinical Use of β-Andrenoceptor Blockade in Systemic HypertensionNadelmann J, Frishman W. Clinical Use of β-Andrenoceptor Blockade in Systemic Hypertension. Drugs 1990, 39: 862-876. PMID: 1973382, DOI: 10.2165/00003495-199039060-00005.ChaptersCitationsMeSH Keywords and ConceptsMeSH KeywordsAdrenergic beta-AntagonistsAdultAgedHumansHypertensionMiddle AgedConceptsΒ-blockersSystemic hypertensionBlood pressureMembrane-stabilising activityIntrinsic sympathomimetic activityDuration of actionSympathomimetic activityPatient groupPharmacokinetic differencesΒ1-selectivityIndividual patientsClinical usePatientsRelative potencyHypertensionBlockade